Single dose intranasal immunization with ISCOMATRIX™ vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract

This publication has 45 references indexed in Scilit:

• Immunoglobulin‐A antibodies in Upper Airway Secretions may Inhibit Intranasal Influenza Virus Replication in Mice but not Protect Against Clinical Illness
  Scandinavian Journal of Immunology, 2005
• Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia
  Vaccine, 2004
• ISCOMATRIXTM adjuvant: a potent inducer of humoral and cellular immune responses
  Vaccine, 2004
• Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccine
  Vaccine, 2003
• Influence of Intravenous Anesthesia on Mucosal and Systemic Antibody Responses to Nasal Vaccines
  Infection and Immunity, 2002
• Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention
  Vaccine, 2002
• Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
  Vaccine, 1996
• The role of nasopharyngeal lymphoid tissue
  Immunology Today, 1992
• Cellular Immune Responses in the Murine Lung to Local Immunization with Influenza A Virus Glycoproteins in Micelles and Immunostimulatory Complexes (Iscoms)
  Scandinavian Journal of Immunology, 1988
• The Serum Antibody Response Distributed in Subclasses and Isotypes after Intranasal and Subcutaneous Immunization with Influenza Virus Immunostimulating Complexes
  Scandinavian Journal of Immunology, 1988